[
  {
    "ruleId": "MED_DOSING_001",
    "name": "Warfarin with Supratherapeutic INR",
    "domain": "DOSING",
    "severity": "BLOCK",
    "provenance": {
      "sourceAuthority": "CHEST/ACCP",
      "sourceDocument": "CHEST Antithrombotic Therapy Guidelines 2022",
      "sourceVersion": "10th-edition",
      "effectiveDate": "2022-01-01",
      "jurisdiction": "INTL",
      "citationUrl": "https://journal.chestnet.org/",
      "licenseType": "proprietary"
    },
    "logic": {
      "and": [
        { ">": [{ "var": "patient_inr" }, 4.0] },
        { "!": { "in": ["Hold Warfarin", { "var": "proposed_action" }] } }
      ]
    },
    "intervention": {
      "message": "INR is supratherapeutic (> 4.0). Continuing warfarin increases bleeding risk.",
      "recommendation": "Hold warfarin. Consider Vitamin K if INR > 10 or bleeding present. Recheck INR in 24-48 hours."
    },
    "tags": ["anticoagulation", "warfarin", "inr"]
  }
]
